PT - JOURNAL ARTICLE AU - Zhikun Yang AU - Jingyun Yang AU - Di Liu AU - Weihong Yu TI - Mendelian randomization analysis identified genes pleiotropically associated with central corneal thickness AID - 10.1101/2021.02.27.21252574 DP - 2021 Jan 01 TA - medRxiv PG - 2021.02.27.21252574 4099 - http://medrxiv.org/content/early/2021/03/02/2021.02.27.21252574.short 4100 - http://medrxiv.org/content/early/2021/03/02/2021.02.27.21252574.full AB - Objective To prioritize genes that were pleiotropically or potentially causally associated with central corneal thickness (CCT).Methods We applied the summary data-based Mendelian randomization (SMR) method integrating summarized data of genome-wide association study (GWAS) on CCT and expression quantitative trait loci (eQTL) data to identify genes that were pleiotropically associated with CCT. We performed separate SMR analysis using CAGE eQTL data and GTEx eQTL data. SMR analysis were done for participants of European and East Asian ancestries, separately.Results We identified multiple genes showing pleiotropic association with CCT in the participants of European ancestry. CLIC3 (ILMN_1796423; PSMR=4.15×10−12), PTGDS (ILMN_1664464; PSMR=6.88×10−9) and C9orf142 (ILMN_1761138; PSMR=8.09×10−9) were the top three genes using the CAGE eQTL data, and RP11-458F8.4(ENSG00000273142.1; PSMR=5.89×10−9), LCNL1 (ENSG00000214402.6; PSMR=5.67×10−8), and PTGDS (ENSG00000107317.7; PSMR=1.92×10−7) were the top three genes using the GTEx eQTL data. No genes showed significantly pleiotropic association with CCT in the participants of East Asian ancestry after correction for multiple testing.Conclusion We identified several genes pleiotropically associated with CCT, some of which represented novel genes influencing CCT. Our findings provided important leads to a better understanding of the genetic factors influencing CCT, and revealed potential therapeutic targets for the treatment of primary open-angle glaucoma and keratoconus.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThe study was supported by Beijing Tianjin Hebei Basic Research Cooperation Project (J200006); Pharmaceutical Collaborative Innovation Research Project of Beijing Science and Technology Commission (L192062); and National Key Research and Development Project (SQ2018YFC200148). The research of Dr. Jingyun Yang was supported by NIH/NIA grants P30AG10161, R01AG15819, R01AG17917, R01AG36042, U01AG61356 and 1RF1AG064312-01. Di Liu was supported by China Scholarship Council (CSC 201908110339).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:No IRB/oversight body was required for this study.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data, models, or code generated or used during the study are available in a repository or online in accordance with funder data retention policies.The eQTL data can be downloaded at https://cnsgenomics.com/data/SMR/#eQTLsummarydata.The GWAS summarized data can be downloaded at https://datashare.is.ed.ac.uk/handle/10283/2976. https://cnsgenomics.com/data/SMR/#eQTLsummarydata https://datashare.is.ed.ac.uk/handle/10283/2976